Document is current
Any future updates will be listed below
-
Authors
Vallini, Giulia https://orcid.org/0000-0002-9634-8401
Silvestri, Erica https://orcid.org/0000-0002-1853-0777
Volpi, Tommaso https://orcid.org/0000-0002-5451-6710
Lee, John J. https://orcid.org/0000-0003-2269-6267
Vlassenko, Andrei G.
Goyal, Manu S. https://orcid.org/0000-0003-1970-4270
Cecchin, Diego https://orcid.org/0000-0001-7956-1924
Corbetta, Maurizio https://orcid.org/0000-0001-8295-3304
Bertoldo, Alessandra https://orcid.org/0000-0002-6262-6354
-
Funding
Funding for this research was provided by:
NIH/NIA (R01AG053503)
- License Information
-
More Information
Article History
Received: 10 March 2024
Accepted: 29 September 2024
First Online: 30 October 2024
Declarations
:
: All assessments and imaging procedures were approved by Human Research Protection Office and Radioactive Drug Research Committee at Washington University in St. Louis (healthy controls). Concerning glioma patients, the protocol has been approved by the local Ethics Committee of the University Hospital of Padova. All procedures performed in studies were conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.
: Informed written consent was obtained from all individual participants included in the study.
: Participants signed informed consent regarding publishing their data.
: The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
